Delivery Order SPE2DB20D3103-SPE2DB21FQ1C8

Award Date 9/1/21
Potential Completion Date 9/2/21
Potential Value $7.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of EpiPen Jr. 2-Pak 0.15 mg Injectors to the Defense Logistics Agency (DLA). The firm fixed-price delivery order, valued at $9,456.58, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. This IDC serves as a primary vehicle for providing...
This federal contract award is for the delivery of EpiPen Jr. 2-Pak 0.15 mg injectors to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,953.80 and a completion date of June 2, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract was awarded on June 1, 2023 and there is no set-aside designation indicated....
This federal contract award is for the delivery of EpiPen Jr. 2-Pak 0.15 mg auto-injectors. The contract was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order valued at $1,935.12 with a firm fixed price. It does not have a set-aside designation, indicating open competition. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of EpiPen Jr. 2-Pak 0.15 mg injectors. The contract has a ceiling value of $1,612.50 and is a firm-fixed-price delivery order. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through November 2026. This IDC serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,273.32, is for the delivery of EpiPen Jr 2-Pak 0.15 mg injectors. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Cencora,...
This federal contract award is for the delivery of EpiPen 2-Pak 0.3 mg auto-injectors to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,614.62, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on September 16, 2021. The contract is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This single-award IDC...
This federal contract award, valued at $32,882.32, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EpiPen Jr. 2-Pak 0.15 mg Injectors, a critical medical product used to treat severe allergic reactions. The award is a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award from the Defense Logistics Agency (DLA) is for the supply of EpiPen Jr 2-Pak 0.15 mg auto-injectors. The $2,977.67 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is for the delivery of EpiPen 2-Pak 0.3 mg auto-injectors to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,884.27 and is a firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of April 26, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,507.87 firm fixed-price delivery order is for the supply of EpiPen Jr 2-Pak 0.15 mg auto-injectors, with a completion date of December 30, 2021. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB21FQ1C8
    Delivery Order

This federal contract award is for the delivery of EpiPen Jr. 2-Pak 0.15 mg injectors to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on September 1, 2021 with a ceiling value of $7,128.89. This award is a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other critical medical commodities to support military healthcare programs globally. This specific contract award does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 10:59 AM